Field
Injectable Pharma products and blood derived products
Address
Calle 23, sq 268, San agustin, La Lisa, Havana.
Contact person's name
Odalys Madrazo
Short description of the company
AICA+ Laboratories researches, produces and distributes injectable generic medicines, ophthalmic solutions, large volume parenterals, blood derivatives products and Homeopathic Medicines; it also provides production and analytical services to improve the patient quality of life. The company has 5 manufacturing facilities and a Research, developed and innovating unit. With 16 manufacturing lines, it is able to produce more than 120 millions of units per year. Our portfolio has 198 products of 7 Pharmaceutical forms (Ampoules, Liquids vials, Lyophilized Vials, Cartridges, Large volume parenterals, Blood Derivatives Products, Homeopathic Medicines and Ophthalmic Solutions). The company is certified by ISO-9001-2015 Quality Management System certified by ONN, AENOR and IQNet, it also has GMP certificate and Good Manufacture Practices Certification by CECMED.
Company`s description
AICA+ Laboratories belongs to the BioCubaFarma Group. It is recognized for its specialization in the production of generic medicines in injectable liquid, lyophilized pharmaceutical forms, eye drops, ear and nasal drops, carpules, cytostatics, large volume parenterals, blood derivatives products and Homeopathic Medicines. With a history of more than 20 years, it has been able to consolidate an image of excellence, responsibility and sustainability. It offers a wide portfolio of products which include 28 Pharmacological Groups and meet the needs of the different programs of the Cuban Health system and international clients.
The company has 5 manufacturing facilities with 16 manufacturing lines and a Research, developed and innovating unit. Our portfolio has 198 products of 7 Pharmaceutical forms. The production of these medicines is carried out under strict compliance with the Good Medicine Manufacturing Practices and on the basis of a quality management system. It has experience in technology transfer and has carried out solid exchange work with medical specialties to establish strategies for the development, marketing and pharmacovigilance of new products. The company is certified by ISO-9001-2015 Quality Management System certified by ONN, AENOR and IQNet, it also has GMP certificate and Good Manufacture Practices Certification by CECMED
Partner search
Biopharma project, regulatory, transdermal projects
Short content description
In the previously presented project proposals related to transdermal patches for the treatment of pain, blood derivatives products (specific immunoglobulins) and products for cancer treatment, our interests are related to: Market access, Financing, Advice on regulatory issues, Scientific-technical exchange and training, Technology transfer, Research and joint developments.
The programme is co-financed by the Slovenian Enterprise Fund and the European Union, namely from the European Fund for Regional Development. It is carried out on the basis of the Substantial Support of Fund Recipients (SME) programme from 2018 to 2023 within the framework of the Operational Programme for the Implementation of European Cohesion Policy from 2014 to 2020.
